Regulatory Perspectives on Continuous Pharmaceutical Manufacturing: Moving From Theory to Practice
Moheb Nasr(Centre for Innovation in Regulatory Science), Sau L. Lee(United States Food and Drug Administration), Alastair J. Florence(University of Strathclyde), Konstantin Konstantinov(University of Wollongong), Salvatore Mascia(Massachusetts Institute of Technology), Keith D. Jensen(IIT@MIT), Clive Badman(GlaxoSmithKline (United Kingdom)), Markus Krumme(Novartis (Switzerland)), Yoshihiro Matsuda(Pharmaceuticals and Medical Devices Agency), Bernhardt L. Trout(IIT@MIT), Charles L. Cooney(IIT@MIT), Craig A. Johnston(University of Houston)
Cited by 138
Related Papers
End‐to‐End Continuous Manufacturing of Pharmaceuticals: Integrated Synthesis, Purification, and Final Dosage Formation
|Angewandte Chemie International Edition|2013|599
Advocating for Behavior Change With Education
|American Journal of Lifestyle Medicine|2017|407
Boosting potassium-ion batteries by few-layered composite anodes prepared via solution-triggered one-step shear exfoliation
|Nature Communications|2018|252
School Year Versus Summer Differences in Child Weight Gain: A Narrative Review
|Childhood Obesity|2014|182
Changes in Weight Over the School Year and Summer Vacation: Results of a 5‐Year Longitudinal Study
|Journal of School Health|2013|162